Home / Inspections / 1167505

FDA Inspection 1167505 — Cambrex Profarmaco Milano Srl

Cambrex Profarmaco Milano Srl — FEI 3003723076

The FDA completed an inspection of Cambrex Profarmaco Milano Srl on October 1, 2021 in Paullo. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 1, 2021
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Paullo (Italy)

Additional Details

Mutual Recognition Agreement (MRA)

Facility

Other inspections at this facility

  • 1193220 (NAI Fri Nov 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1091698 (NAI Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1021644 (VAI Fri May 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 973972 (VAI Fri Nov 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 861141 (NAI Fri Dec 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources